Familial combined hyperlipidaemia/polygenic mixed hyperlipidaemia

Area of Science:

• Cardiology
• Genetics
• Metabolic Disorders

Background:

• Familial combined hyperlipidaemia (FCH) is the most common inherited lipid disorder.
• It has a multigenic origin, influenced by genetic and environmental factors.
• FCH significantly elevates cardiovascular disease risk and is often linked to metabolic syndrome.

Purpose of the Study:

• To review recent advances in understanding Familial Combined Hyperlipidaemia.
• To increase awareness of FCH among healthcare professionals.
• To improve the clinical management and cardiovascular prevention strategies for FCH patients.

Main Methods:

• Literature review of recent studies on FCH.
• Analysis of genetic and environmental interactions in FCH.
• Synthesis of current clinical guidelines and research findings.

Main Results:

• FCH is underdiagnosed and undertreated, despite its cardiovascular implications.
• Recent research clarifies the oligogenic nature and complex inheritance of FCH.
• Advances in understanding FCH contribute to better risk stratification.

Conclusions:

• Increased awareness and improved diagnostic approaches are crucial for FCH.
• Timely and effective treatment of FCH is essential for cardiovascular prevention.
• Further research is needed to optimize the clinical control of FCH.